Akero Therapeutics, Inc.
Ticker: AKRO
| Insider | Title |
|---|---|
| Andrew Cheng | President and CEO, Director |
| Catriona Yale | Chief Development Officer |
| Chou Judy | Director |
| G. Walmsley Graham | Director |
| Horizon Enterprise Ltd Blue | Former 10% owner |
| Iii Gp, Ltd. Atp | 10% or greater ownership |
| International Ltd Ezbon | Former 10% owner |
| Jane Henderson | Director |
| Jonathan Young | Chief Operating Officer |
| Kevin Bitterman | Director |
| Life Science Ventures, L.p. Atp | 10% or greater ownership |
| Mark T Iwicki | Director |
| Patrick Lamy | Senior VP, Commercial Strategy |
| Scott A. Gangloff | Chief Technology Officer |
| Seth Loring Harrison | Director |
| Timothy Rolph | Chief Scientific Officer |
| Tomas J. Heyman | Director |
| Trust Skorpios | Former 10% owner |
| Trustees Ltd Montrago | Former 10% owner |
| William Richard White | Chief Financial Officer |
| Yuan Xu | Director |